Tumor suppressor p53 and its gain-of-function mutants in cancer
about
Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinomaTelomeres and telomerase in head and neck squamous cell carcinoma: from pathogenesis to clinical implications.Significant Prognostic Features and Patterns of Somatic TP53 Mutations in Human CancersAdiposity is associated with p53 gene mutations in breast cancerUSP11 regulates p53 stability by deubiquitinating p53.Development of cancer-initiating cells and immortalized cells with genomic instability.p53 signaling is involved in leptin-induced growth of hepatic and breast cancer cells.Photoprotection in changing times - UV filter efficacy and safety, sensitization processes and regulatory aspects.MicroRNA expression patterns and target prediction in multiple myeloma development and malignancy.G protein subunit α q regulates gastric cancer growth via the p53/p21 and MEK/ERK pathways.P53 mutations and cancer: a tight linkage.Mechanisms of p53 Functional De-Regulation: Role of the IκB-α/p53 ComplexMutant p53 stimulates cell invasion through an interaction with Rad21 in human ovarian cancer cells.Peritoneal Mesothelioma with Residential Asbestos Exposure. Report of a Case with Long Survival (Seventeen Years) Analyzed by Cgh-Array.Effect of hesperidin on mice bearing Ehrlich solid carcinoma maintained on doxorubicin.Efficient generation of P53 biallelic knockout Diannan miniature pigs via TALENs and somatic cell nuclear transfer.Gene expression profile comparison between colorectal cancer and adjacent normal tissues.Pathway enrichment analysis approach based on topological structure and updated annotation of pathway.Potential Molecular Targets in the Treatment of Lung Cancer Using siRNA Technology.Advances in the mechanisms of action of cancer-targeting oncolytic viruses.Glioblastoma multiforme-derived extracellular vesicles drive normal astrocytes towards a tumour-enhancing phenotype.Deoxyribonucleotide Triphosphate Metabolism in Cancer and Metabolic Disease.TP53 Arg72Pro polymorphism is associated with increased overall survival but not response to therapy in Portuguese/Caucasian patients with advanced cervical cancer.Comparison of Burnet's clonal selection theory with tumor cell-clone development.Mutant p53 gain of function induces HER2 over-expression in cancer cells.Deep RNA sequencing reveals the dynamic regulation of miRNA, lncRNAs, and mRNAs in osteosarcoma tumorigenesis and pulmonary metastasis.NF-κB-related decrease of glioma angiogenic potential by graphite nanoparticles and graphene oxide nanoplateletsTargeted Therapies in Type II Endometrial Cancers: Too Little, but Not Too LateAssociation Between Genetic Variant in the Promoter of Pri-miR-34b/c and Risk of Glioma
P2860
Q28084948-D672D87F-5835-41B9-A6D4-8316B3250BFEQ30248577-2F3F2657-9428-4E7F-AFEE-16BDBFAEF772Q33565858-199D9E79-ED8B-46DA-97B9-8F977E4DE82EQ33908211-41ADBD2C-13F3-4763-A756-5CAAFBA51EBBQ34696209-135568EF-92E5-4DEA-A615-20D41D87EF42Q35205699-5AC25D31-CAD7-4ACA-BFA6-80B0098D7619Q37239773-4EFA92CE-574A-4C0E-B75A-F9751A345223Q38254382-F557C4C8-BC2D-4B5C-97B8-ECD1924960A4Q38689170-8FC4F23D-3828-4E43-950A-D934A95F6B96Q38710066-2C5253DB-02B5-482D-BCD2-E24BC2AE79F7Q38763097-E1958CE8-0794-4D17-B2F6-57CE72F0B25DQ39029101-3755AB96-FE5B-47F9-8703-232726253581Q41490261-6FF2F154-B0FE-48DC-9B50-B0999FF7DF10Q42352210-5D6CAB18-40A6-4FEF-AD80-6A6699374B62Q46350707-62247C58-74E4-4023-AA8A-25F022892974Q47094378-E57C0484-A995-4076-92BD-9B8C0EA44D68Q47099108-B3648CF8-D980-4437-B2C1-4DEF42E7581EQ47884625-F3AE2999-D378-4E2F-BB4A-52789FDCE687Q48536576-59C5464E-56BD-45A8-8DF7-EF2B3DDB5406Q52655195-2794CFA4-52DC-42ED-A778-F3CA779A72A6Q52776751-9C8CEDFF-63D8-4FAB-AA81-B28BC4B6E1ECQ53688741-A5465982-5D02-4620-9FC4-2BF4894AF369Q55060818-553EA4AC-C5A6-4DFC-9B87-0BC75A53F289Q55422912-6C7CFF9E-E6F5-4E56-9E24-EE2AE1A2DB81Q55455939-697C9722-B858-4EFA-9492-A5855B8E6493Q55663842-22E82707-2F31-4FC3-9E16-11CC37016138Q57041673-3581A3F0-C821-4C38-9B26-2439A38F3190Q57169683-BE3B810D-3F28-45C2-B46E-A18E872B427CQ57491541-7CD98660-E84F-47DF-AC35-C6C0D1CA2154
P2860
Tumor suppressor p53 and its gain-of-function mutants in cancer
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Tumor suppressor p53 and its gain-of-function mutants in cancer
@ast
Tumor suppressor p53 and its gain-of-function mutants in cancer
@en
Tumor suppressor p53 and its gain-of-function mutants in cancer
@nl
type
label
Tumor suppressor p53 and its gain-of-function mutants in cancer
@ast
Tumor suppressor p53 and its gain-of-function mutants in cancer
@en
Tumor suppressor p53 and its gain-of-function mutants in cancer
@nl
prefLabel
Tumor suppressor p53 and its gain-of-function mutants in cancer
@ast
Tumor suppressor p53 and its gain-of-function mutants in cancer
@en
Tumor suppressor p53 and its gain-of-function mutants in cancer
@nl
P2093
P2860
P3181
P356
P1476
Tumor suppressor p53 and its gain-of-function mutants in cancer
@en
P2093
P2860
P3181
P356
10.1093/ABBS/GMT144
P407
P577
2014-03-01T00:00:00Z